FIELD: medicine.
SUBSTANCE: invention concerns medicine and is intended for treatment of a HIV-infected and patients with AIDS. A transcutaneous irradiation with impulsive light on a projection of lymph nodes and-or an osteal brain simultaneously with the group of lengths of waves: 516.7, 517.2, 518.2, 636.2 and group of lengths of waves 874.0; 732.6; 403.0 nanometres and-or group of lengths of waves 396.8; 393.3 nanometres is performed. Frequency of the following impulses makes 1-10 Hz, power of an irradiation in limits from 50 to 1000 W.
EFFECT: depression of a virus load and rising of quantity of cells of CDs-4-lymphocytes, not causing collateral toxic effects.
3 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF THERAPEUTIC INFLUENCE ON PERSONS INFECTED WITH VIRUS OF HERPES | 2007 |
|
RU2359720C2 |
| METHOD FOR ACTING UPON AIDS VIRUS | 2003 |
|
RU2245178C1 |
| DEVICE FOR TREATING AIDS VIRUS INFECTION | 2003 |
|
RU2248230C1 |
| METHOD OF INACTIVATION OF AIDS VIRUS | 1996 |
|
RU2097427C1 |
| METHOD FOR INACTIVATING AIDS VIRUS | 2003 |
|
RU2252046C1 |
| METHOD FOR COMPLEX- INDIVIDUALIZED IMPACT UPON BODY AT SLOW VIRAL INFECTION AND METHOD FOR PREPARING LABORATORY ANIMAL FOR TESTING THE METHOD OF SUCH IMPACT | 2001 |
|
RU2207876C1 |
| METHOD OF INACTIVATION OF AIDS VIRUS | 1992 |
|
RU2031945C1 |
| METHOD FOR INACTIVATING AIDS VIRUS | 2003 |
|
RU2223124C1 |
| CCR5 EXPRESSION SUPRESSION COMPOSITIONS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2353357C2 |
| NOVEL QUINOLINE DERIVATIVE FOR USE IN TREATING AND PREVENTING VIRAL INFECTIONS | 2016 |
|
RU2723013C2 |
